Selective Elimination of Amplified CDK4 Sequences Correlates with Spontaneous Adipocytic Differentiation in Liposarcoma

被引:28
|
作者
Helias-Rodzewicz, Zofia [1 ,2 ]
Pedeutour, Florence [3 ,4 ]
Coindre, Jean-Michel [5 ]
Terrier, Philippe [6 ]
Aurias, Alain [1 ,2 ]
机构
[1] Inst Curie Genet & Biol Canc, F-75248 Paris 05, France
[2] INSERM U830, F-75248 Paris 05, France
[3] Nice Univ Hosp, Lab Solid Tumors Genet, F-06107 Nice, France
[4] Fac Med Nice, CNRS UMR 6543, F-06107 Nice, France
[5] Inst Bergonie, Dept Pathol, F-33076 Bordeaux, France
[6] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
来源
GENES CHROMOSOMES & CANCER | 2009年 / 48卷 / 11期
关键词
SOFT-TISSUE TUMORS; SUPERNUMERARY RING CHROMOSOMES; DOUBLE-MINUTE CHROMOSOMES; LIPOMATOUS TUMORS; X-CHROMOSOME; DEDIFFERENTIATED LIPOSARCOMAS; CYTOGENETIC FINDINGS; MYC GENES; C-MYC; CELLS;
D O I
10.1002/gcc.20696
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Well-differentiated and undifferentiated liposarcomas are characterized by high-level amplifications of chromosome 12 regions including the CDK4 and MDM2 genes. These amplicons are either localized, in well-differentiated liposarcoma (WDLPS), on extrachromosomal structures (ring or rod chromosomes), or integrated into chromosome arms in undifferentiated tumors. Our results reveal that extrachromosomal amplicons are unstable, and frequently lost by micronucleation. This loss correlates with hypermethylation of eliminated sequences and changes of their replication time. Treatment of cells with demethylating agents during early S-phase significantly decreases the rate of micronuclei positive for CDK4. We also demonstrate that, in our model, micronuclei are generated during anaphase as a consequence of anaphase abnormalities (chromosome lagging and anaphase bridges). Finally, a dramatic increase of adipocytic differentiation was noted in cells that have eliminated copies of CDK4 gene in micronuclei. These findings provide evidence that, in WDLPS, adipocytic differentiation could be the consequence of CDK4 loss, an event occurring rarely in undifferentiated tumors in which the amplified sequences are integrated into chromosome arms. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:943 / 952
页数:10
相关论文
共 50 条
  • [31] Efficacy of a CDK4/6 Inhibitor in a Patient with Breast Cancer and Liposarcoma: A Case Report and Review of the Literature
    Loretan, Laura
    Moskovszky, Linda Eszter
    Kurrer, Michael
    Exner, G. Ulrich
    Trojan, Andreas
    BREAST CARE, 2019, 14 (05) : 325 - 328
  • [32] Functional switching of Runx2 by Cdk6 and Cdk4 in regulation of osteoblast differentiation
    Ogasawara, T
    Chikuda, H
    Ohba, S
    Chikazu, D
    Katagiri, M
    Yano, F
    Nakamura, K
    Chung, U
    Hoshi, K
    Takato, T
    Okayama, H
    Kawaguchi, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S5 - S5
  • [33] Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis
    Hao Wu
    Liming Xia
    Haichao Xu
    Biochemical Genetics, 2022, 60 : 1095 - 1106
  • [34] Detection of CDK4 germline pathogenic variant in the patient with liposarcoma through whole genome sequencing analysis
    Oda, Satoyo
    Kubo, Takashi
    Yoshida, Akihiko
    Chiba, Kenichi
    Shiraishi, Yuichi
    Toda, Yu
    Koyama, Takafumi
    Yamamoto, Noboru
    Kobayashi, Eisuke
    Sunami, Kuniko
    Hirata, Makoto
    CANCER SCIENCE, 2025, 116 : 1114 - 1114
  • [35] Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis
    Wu, Hao
    Xia, Liming
    Xu, Haichao
    BIOCHEMICAL GENETICS, 2022, 60 (03) : 1095 - 1106
  • [36] Co-amplification of CDK4 and MDM2 plus HMGA2 fusion in a patient with myogenic differentiation dedifferentiated liposarcoma.
    Huang, Gang
    Li, Xianan
    Wang, Chunyang
    He, Qifan
    Wang, Xiaojuan
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Promotion of Myoblast Differentiation by Fkbp5 via Cdk4 Isomerization
    Ruiz-Estevez, Mercedes
    Staats, James
    Paatela, Ellen
    Munson, Dane
    Katoku-Kikyo, Nobuko
    Yuan, Ce
    Asakura, Yoko
    Hostager, Reilly
    Kobayashi, Hiroshi
    Asakura, Atsushi
    Kikyo, Nobuaki
    CELL REPORTS, 2018, 25 (09): : 2537 - +
  • [38] The CDK4/6 Inhibitor Palbociclib Synergizes with ATRA to Induce Differentiation in AML
    Hu, Linhui
    Li, Qian
    Wang, Jiyu
    Wang, Huiping
    Ren, Xiyang
    Huang, Keke
    Wang, Yangyang
    Liang, Xue
    Pu, Lianfang
    Xiong, Shudao
    Zhai, Zhimin
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (07) : 961 - 972
  • [39] Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas
    Burns, KL
    Ueki, K
    Jhung, SL
    Koh, J
    Louis, DN
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (02): : 122 - 130
  • [40] Structure-based design of potent CDK4 selective inhibitor.
    Honma, T
    Hayashi, K
    Kawanishi, N
    Yoshizumi, T
    Hashimoto, N
    Sugimoto, T
    Nakamura, K
    Takaki, T
    Machida, T
    Fukasawa, K
    Hirai, H
    Iwama, T
    Ikeura, C
    Ikuta, M
    Kamata, K
    Suzuki-Takahashi, I
    Hayama, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U24 - U24